Cargando…

SOX17 Regulates Conversion of Human Fibroblasts Into Endothelial Cells and Erythroblasts by Dedifferentiation Into CD34(+) Progenitor Cells

BACKGROUND: The mechanisms underlying the dedifferentiation and lineage conversion of adult human fibroblasts into functional endothelial cells have not yet been fully defined. Furthermore, it is not known whether fibroblast dedifferentiation recapitulates the generation of multipotent progenitors d...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lianghui, Jambusaria, Ankit, Hong, Zhigang, Marsboom, Glenn, Toth, Peter T., Herbert, Brittney-Shea, Malik, Asrar B., Rehman, Jalees
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472005/
https://www.ncbi.nlm.nih.gov/pubmed/28381471
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.025722
_version_ 1783244065748287488
author Zhang, Lianghui
Jambusaria, Ankit
Hong, Zhigang
Marsboom, Glenn
Toth, Peter T.
Herbert, Brittney-Shea
Malik, Asrar B.
Rehman, Jalees
author_facet Zhang, Lianghui
Jambusaria, Ankit
Hong, Zhigang
Marsboom, Glenn
Toth, Peter T.
Herbert, Brittney-Shea
Malik, Asrar B.
Rehman, Jalees
author_sort Zhang, Lianghui
collection PubMed
description BACKGROUND: The mechanisms underlying the dedifferentiation and lineage conversion of adult human fibroblasts into functional endothelial cells have not yet been fully defined. Furthermore, it is not known whether fibroblast dedifferentiation recapitulates the generation of multipotent progenitors during embryonic development, which give rise to endothelial and hematopoietic cell lineages. Here we established the role of the developmental transcription factor SOX17 in regulating the bilineage conversion of fibroblasts by the generation of intermediate progenitors. METHODS: CD34(+) progenitors were generated after the dedifferentiation of human adult dermal fibroblasts by overexpression of pluripotency transcription factors. Sorted CD34(+) cells were transdifferentiated into induced endothelial cells and induced erythroblasts using lineage-specific growth factors. The therapeutic potential of the generated cells was assessed in an experimental model of myocardial infarction. RESULTS: Induced endothelial cells expressed specific endothelial cell surface markers and also exhibited the capacity for cell proliferation and neovascularization. Induced erythroblasts expressed erythroid surface markers and formed erythroid colonies. Endothelial lineage conversion was dependent on the upregulation of the developmental transcription factor SOX17, whereas suppression of SOX17 instead directed the cells toward an erythroid fate. Implantation of these human bipotential CD34(+) progenitors into nonobese diabetic/severe combined immunodeficiency (NOD-SCID) mice resulted in the formation of microvessels derived from human fibroblasts perfused with mouse and human erythrocytes. Endothelial cells generated from human fibroblasts also showed upregulation of telomerase. Cell implantation markedly improved vascularity and cardiac function after myocardial infarction without any evidence of teratoma formation. CONCLUSIONS: Dedifferentiation of fibroblasts to intermediate CD34(+) progenitors gives rise to endothelial cells and erythroblasts in a SOX17-dependent manner. These findings identify the intermediate CD34(+) progenitor state as a critical bifurcation point, which can be tuned to generate functional blood vessels or erythrocytes and salvage ischemic tissue.
format Online
Article
Text
id pubmed-5472005
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-54720052017-06-30 SOX17 Regulates Conversion of Human Fibroblasts Into Endothelial Cells and Erythroblasts by Dedifferentiation Into CD34(+) Progenitor Cells Zhang, Lianghui Jambusaria, Ankit Hong, Zhigang Marsboom, Glenn Toth, Peter T. Herbert, Brittney-Shea Malik, Asrar B. Rehman, Jalees Circulation Original Research Articles BACKGROUND: The mechanisms underlying the dedifferentiation and lineage conversion of adult human fibroblasts into functional endothelial cells have not yet been fully defined. Furthermore, it is not known whether fibroblast dedifferentiation recapitulates the generation of multipotent progenitors during embryonic development, which give rise to endothelial and hematopoietic cell lineages. Here we established the role of the developmental transcription factor SOX17 in regulating the bilineage conversion of fibroblasts by the generation of intermediate progenitors. METHODS: CD34(+) progenitors were generated after the dedifferentiation of human adult dermal fibroblasts by overexpression of pluripotency transcription factors. Sorted CD34(+) cells were transdifferentiated into induced endothelial cells and induced erythroblasts using lineage-specific growth factors. The therapeutic potential of the generated cells was assessed in an experimental model of myocardial infarction. RESULTS: Induced endothelial cells expressed specific endothelial cell surface markers and also exhibited the capacity for cell proliferation and neovascularization. Induced erythroblasts expressed erythroid surface markers and formed erythroid colonies. Endothelial lineage conversion was dependent on the upregulation of the developmental transcription factor SOX17, whereas suppression of SOX17 instead directed the cells toward an erythroid fate. Implantation of these human bipotential CD34(+) progenitors into nonobese diabetic/severe combined immunodeficiency (NOD-SCID) mice resulted in the formation of microvessels derived from human fibroblasts perfused with mouse and human erythrocytes. Endothelial cells generated from human fibroblasts also showed upregulation of telomerase. Cell implantation markedly improved vascularity and cardiac function after myocardial infarction without any evidence of teratoma formation. CONCLUSIONS: Dedifferentiation of fibroblasts to intermediate CD34(+) progenitors gives rise to endothelial cells and erythroblasts in a SOX17-dependent manner. These findings identify the intermediate CD34(+) progenitor state as a critical bifurcation point, which can be tuned to generate functional blood vessels or erythrocytes and salvage ischemic tissue. Lippincott Williams & Wilkins 2017-06-20 2017-06-19 /pmc/articles/PMC5472005/ /pubmed/28381471 http://dx.doi.org/10.1161/CIRCULATIONAHA.116.025722 Text en © 2017 The Authors. Circulation is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made.
spellingShingle Original Research Articles
Zhang, Lianghui
Jambusaria, Ankit
Hong, Zhigang
Marsboom, Glenn
Toth, Peter T.
Herbert, Brittney-Shea
Malik, Asrar B.
Rehman, Jalees
SOX17 Regulates Conversion of Human Fibroblasts Into Endothelial Cells and Erythroblasts by Dedifferentiation Into CD34(+) Progenitor Cells
title SOX17 Regulates Conversion of Human Fibroblasts Into Endothelial Cells and Erythroblasts by Dedifferentiation Into CD34(+) Progenitor Cells
title_full SOX17 Regulates Conversion of Human Fibroblasts Into Endothelial Cells and Erythroblasts by Dedifferentiation Into CD34(+) Progenitor Cells
title_fullStr SOX17 Regulates Conversion of Human Fibroblasts Into Endothelial Cells and Erythroblasts by Dedifferentiation Into CD34(+) Progenitor Cells
title_full_unstemmed SOX17 Regulates Conversion of Human Fibroblasts Into Endothelial Cells and Erythroblasts by Dedifferentiation Into CD34(+) Progenitor Cells
title_short SOX17 Regulates Conversion of Human Fibroblasts Into Endothelial Cells and Erythroblasts by Dedifferentiation Into CD34(+) Progenitor Cells
title_sort sox17 regulates conversion of human fibroblasts into endothelial cells and erythroblasts by dedifferentiation into cd34(+) progenitor cells
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472005/
https://www.ncbi.nlm.nih.gov/pubmed/28381471
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.025722
work_keys_str_mv AT zhanglianghui sox17regulatesconversionofhumanfibroblastsintoendothelialcellsanderythroblastsbydedifferentiationintocd34progenitorcells
AT jambusariaankit sox17regulatesconversionofhumanfibroblastsintoendothelialcellsanderythroblastsbydedifferentiationintocd34progenitorcells
AT hongzhigang sox17regulatesconversionofhumanfibroblastsintoendothelialcellsanderythroblastsbydedifferentiationintocd34progenitorcells
AT marsboomglenn sox17regulatesconversionofhumanfibroblastsintoendothelialcellsanderythroblastsbydedifferentiationintocd34progenitorcells
AT tothpetert sox17regulatesconversionofhumanfibroblastsintoendothelialcellsanderythroblastsbydedifferentiationintocd34progenitorcells
AT herbertbrittneyshea sox17regulatesconversionofhumanfibroblastsintoendothelialcellsanderythroblastsbydedifferentiationintocd34progenitorcells
AT malikasrarb sox17regulatesconversionofhumanfibroblastsintoendothelialcellsanderythroblastsbydedifferentiationintocd34progenitorcells
AT rehmanjalees sox17regulatesconversionofhumanfibroblastsintoendothelialcellsanderythroblastsbydedifferentiationintocd34progenitorcells